Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-22-029441

Options or other derivatives

  • General Counsel and Secretary acquired 367,639 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fawaz Ali D. · General Counsel and Secretary

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-05-16 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,301 2,301 D
2022-05-16 Grant or award : show line 2 in the form Stock Option (Right to Buy) +3,752 3,752 D
2022-05-16 Grant or award : show line 3 in the form Stock Option (Right to Buy) +361,586 361,586 D
Loading xslF345X03/doc4.xml…